Arcosa Closes $150/Share CRH Merger; ~$7.5B Paid, Shares Delisted
Summary
Arcosa completed its acquisition by CRH Americas: each share converted into $150.00 cash, about $7.5 billion paid in aggregate, and the stock was halted and delisted from the NYSE on October 23, 2026.
Key Events · M&A and Partnerships · ACA
-
CRH Merger Closes at $150 Cash
Merger Sub merged into Arcosa on October 23, 2026, and each outstanding share converted into the right to receive $150.00 in cash, without interest, less applicable withholding.
-
~$7.5 Billion Aggregate Consideration
Aggregate cash paid for the common stock and cash-settled equity awards was approximately $7.5 billion, funded by Parent through a $3.25 billion bridge facility, a $2.5 billion term loan and cash on hand.
-
Credit Facility Terminated, $450.1M Repaid
The $700 million revolver and $700 million term loan were terminated, and about $450.1 million of principal, interest and other amounts were repaid with no material early termination fees.
-
Delisting and Deregistration Underway
Trading was halted before the open on October 23, 2026, removal from the NYSE and NYSE Texas was requested, and Arcosa intends to file a Form 15 to suspend reporting obligations.
Analysis · ACA · Manufacturing
The CRH deal is now done, and for anyone still holding ACA the investment case is over: the position is a cash claim at the merger price, not a bet on the business. Every Arcosa share converted into $150.00 cash, roughly $7.5 billion in total, and the stock stopped trading on the NYSE before the open on October 23. The filing also shows how the company was handed over. The $700 million revolver and $700 million term loan were terminated with about $450.1 million of principal repaid and no material penalties, the entire board and officer slate resigned and was replaced by Merger Sub's, and Arcosa became a wholly owned CRH subsidiary with a token 100-share authorized capital. A Form 15 deregistration will follow, ending public reporting.
How filings like this one have moved
In the 30 days to Oct 23, 2026, 46.2% of the 277 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.67%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ACA was trading at $148.90 on NYSE in the Manufacturing sector, with a market capitalization of approximately $7.3B. This filing was assessed with neutral market sentiment and an importance score of 9 out of 10.